Xanthinderivate

European patent · EP0258191 · Deleted

Register entry

Publication number
EP0258191
Application number
EP87810481
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 25, 1987
Published
Mar 2, 1988
Granted
May 27, 1992
Deleted
Aug 31, 1998
Reason
Annual fee unpaid
IPC classes
C07D 473/06 (2006.01)
A61K 31/52 (2006.01)
Priority
GB A 8620825 28.08.1986
GB A 8702129 30.01.1987
GB A 8703435 13.02.1987
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 15, 1999

    Deleted, fee unpaid

    Published in PIDTJ No 7 in 1999

  2. May 15, 1997

    Address changed

    Owner
    Sandoz AG, Lichtstrasse 35, 4002 Basel → Novartis AG, Schwarzwaldallee 215, 4058 Basel

    Published in PIDTJ No 9 in 1997

  3. Jul 15, 1992

    Granted

    Published in PIDTJ No 13 in 1992

Parties

Holder

Novartis AG

Schwarzwaldallee 215, 4058 Basel

Inventor

Kis, Zoltan L.

CH-4102 Binningen

Morley, John

CH-4123 Allschwil

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.